Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 3
1989 1
1990 1
1992 4
1995 1
1997 2
1998 1
2001 1
2003 4
2004 2
2005 2
2006 3
2007 1
2008 6
2009 1
2010 4
2011 3
2012 5
2013 9
2014 6
2015 5
2016 5
2017 2
2018 7
2019 5
2020 4
2021 4
2022 4
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Sekulic A, et al. Among authors: oro ae. N Engl J Med. 2012 Jun 7;366(23):2171-9. doi: 10.1056/NEJMoa1113713. N Engl J Med. 2012. PMID: 22670903 Free PMC article. Clinical Trial.
Gibbin mesodermal regulation patterns epithelial development.
Collier A, Liu A, Torkelson J, Pattison J, Gaddam S, Zhen H, Patel T, McCarthy K, Ghanim H, Oro AE. Collier A, et al. Among authors: oro ae. Nature. 2022 Jun;606(7912):188-196. doi: 10.1038/s41586-022-04727-9. Epub 2022 May 18. Nature. 2022. PMID: 35585237 Free PMC article.
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa.
Neumayer G, Torkelson JL, Li S, McCarthy K, Zhen HH, Vangipuram M, Jackow J, Rami A, Hansen C, Guo Z, Gaddam S, Pappalardo A, Li L, Cramer A, Roy KR, Nguyen TM, Tanabe K, McGrath PS, Bruckner A, Bilousova G, Roop D, Bailey I, Tang JY, Christiano A, Steinmetz LM, Wernig M, Oro AE. Neumayer G, et al. Among authors: oro ae. bioRxiv [Preprint]. 2023 Mar 1:2023.02.28.529447. doi: 10.1101/2023.02.28.529447. bioRxiv. 2023. PMID: 36909618 Free PMC article. Preprint.
LY6D marks pre-existing resistant basosquamous tumor subpopulations.
Haensel D, Gaddam S, Li NY, Gonzalez F, Patel T, Cloutier JM, Sarin KY, Tang JY, Rieger KE, Aasi SZ, Oro AE. Haensel D, et al. Among authors: oro ae. Nat Commun. 2022 Dec 6;13(1):7520. doi: 10.1038/s41467-022-35020-y. Nat Commun. 2022. PMID: 36473848 Free PMC article.
Advanced treatment for basal cell carcinomas.
Atwood SX, Whitson RJ, Oro AE. Atwood SX, et al. Among authors: oro ae. Cold Spring Harb Perspect Med. 2014 Jul 1;4(7):a013581. doi: 10.1101/cshperspect.a013581. Cold Spring Harb Perspect Med. 2014. PMID: 24985127 Free PMC article. Review.
Is hypoimmunogenic stem cell therapy safe in times of pandemics?
Matheus F, Raveh T, Oro AE, Wernig M, Drukker M. Matheus F, et al. Among authors: oro ae. Stem Cell Reports. 2022 Apr 12;17(4):711-714. doi: 10.1016/j.stemcr.2022.02.014. Epub 2022 Mar 24. Stem Cell Reports. 2022. PMID: 35334219 Free PMC article. Review.
Actin polymerization controls cilia-mediated signaling.
Drummond ML, Li M, Tarapore E, Nguyen TTL, Barouni BJ, Cruz S, Tan KC, Oro AE, Atwood SX. Drummond ML, et al. Among authors: oro ae. J Cell Biol. 2018 Sep 3;217(9):3255-3266. doi: 10.1083/jcb.201703196. Epub 2018 Jun 26. J Cell Biol. 2018. PMID: 29945904 Free PMC article.
Starve a cold, and perhaps a cancer.
Haensel D, Oro AE. Haensel D, et al. Among authors: oro ae. Nat Cell Biol. 2020 Jul;22(7):755-757. doi: 10.1038/s41556-020-0543-7. Nat Cell Biol. 2020. PMID: 32587343 Free PMC article.
100 results